Tocilizumab for KSHV-Associated Multicentric Castleman Disease

Clinical trial NCT01441063 · COMPLETED

Trial details

NCT number: NCT01441063
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Castleman Disease Multicentric Castleman Disease Giant Lymph Node Hyperplasia

Start date: 2011-09-13
Primary completion: 2018-06-06
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.